Product Information

WARFARIN SODIUM 2 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0969 per EA under NDC 00093171310. Its NADAC has been published 597 times since Jun 17, 2015.

FDA first approved this application on Jul 5, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

WARFARIN SODIUM 2 MG TABLET

Warfarin Sodium
$0.0969per EA

Strength

2 mg/1

NDC

00093171310

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

WARFARIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA040616

FDA Approved

7/5/2006

TE Code

AB

On Market Since

5/5/2015

Pharmacological Classes

Vitamin K Antagonist
Vitamin K Inhibitors

Price Statistics

The NADAC for WARFARIN SODIUM 2 MG TABLET has been published 597 times since Jun 17, 2015, and over the history we have for it it has declined 49.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0969 per EA
All-time high$0.1911 (Jul 15, 2015)
All-time low$0.0748 (Apr 22, 2026)
52-week high$0.0969
52-week low$0.0748
Median price$0.1109
Average price$0.1108
Largest weekly change+26.7% (Feb 22, 2023)
Weeks tracked597
Tracking sinceJun 17, 2015

Price History

1W

+1.7%

1M

+4.3%

3M

+11.8%

6M

+28.6%

1Y

+13.6%

3Y

+11.9%

5Y

-12.9%

All

-49.3%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of WARFARIN SODIUM 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for WARFARIN SODIUM 2 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0969 per EA (NDC 00093171310), effective Nov 18, 2026.

How has the price of WARFARIN SODIUM 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for WARFARIN SODIUM 2 MG TABLET has declined 49.3%. It has been tracked across 597 weekly CMS publications since Jun 17, 2015.

What are the highest and lowest recorded NADAC prices for WARFARIN SODIUM 2 MG TABLET?

Since Jun 17, 2015, the NADAC for WARFARIN SODIUM 2 MG TABLET has ranged from a low of $0.0748 (Apr 22, 2026) to a high of $0.1911 (Jul 15, 2015), with a median of $0.1109 per EA.

Are there cheaper alternatives to WARFARIN SODIUM 2 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, JANTOVEN 2 MG TABLET, is $0.0930 per EA — about 4% below WARFARIN SODIUM 2 MG TABLET.

Who manufactures WARFARIN SODIUM 2 MG TABLET?

WARFARIN SODIUM 2 MG TABLET (NDC 00093171310) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.